Article

New toric IOL standard addresses residual astigmatism

The American National Standards Institute Z80 Accredited Standards Committee for Ophthalmic Optics has announced a new standard for toric IOLs.

Alexandria, VA-The American National Standards Institute (ANSI) Z80 Accredited Standards Committee for Ophthalmic Optics has announced a new standard for toric IOLs.

The standard applies to any monofocal IOL designed primarily to reduce astigmatism to correct aphakia or modify the refractive power of a phakic eye. It does not include IOLs used to correct presbyopia.

The new ANSI Z80.30 standard addresses the vocabulary, optical properties and test methods, mechanical properties and test methods, labeling, biocompatibility, sterility, shelf-life and transport stability, and clinical investigations necessary for IOLs, according to the organization. Specifically, it addresses the requirements and test methods for IOLs used to correct inherent residual astigmatism in the aphakic eye.

“After the crystalline lens of the eye has been removed, toric lens implants can modify the residual refractive state in such an eye . . . to reduce preoperatively or intraoperatively measured astigmatic refractive error that generally arises from the cornea,” said Carl Tubbs, MD, chairman of the ANSI Z80 Subcommittee on Medical Ophthalmic Devices. “This standard will help to ensure that patients receive the best IOLs possible.”

The new ANSI Z80.30 standard for toric IOLs can be purchased at the ANSI Web store, http://webstore.ansi.org/.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.